Needham & Company Reiterates Buy as Radisys Corp's (RSYS) 4Q Results Come In-Line with Preannouncement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Pre-Open Stock Movers 02/10: (BTU) (AKAM) (EDE) Higher; (MSTX) (CTIC) (SCTY) Lower (more...)
February 10, 2016 9:30 AM ESTMast Therapeutics, Inc. (NYSE: MSTX) 39.8% LOWER; today announced the pricing of an underwritten public offering of 29,090,910 units at a price to the public of $0.275 per unit.
CTI BioPharma (Nasdaq: CTIC) 37.2% LOWER; provided an update regarding the clinical studies being conducted under the Company's Investigational New Drug application for pacritinib. Following the issuance of the Company's February 8, 2016, press release describing the partial clinical hold issued by... More
After-Hours Stock Movers 02/09: (LLNW) (EDE) (MKTO) Higher; (MSTX) (SCTY) (P) Lower (more...)
February 9, 2016 6:12 PM ESTMast Therapeutics, Inc. (NYSE: MSTX) 37% LOWER; announced that it intends to offer shares of common stock and warrants to purchase common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
SolarCity (Nasdaq: SCTY) 32.4% LOWER; reported Q4 EPS of ($2.37), $0.22 better than the analyst estimate of ($2.59). Revenue was $115 million, versus... More
Radisys Corp (RSYS) Tops Q4 EPS by 1c
February 9, 2016 5:01 PM ESTRadisys Corp (NASDAQ: RSYS) reported Q4 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $44.1 million versus the consensus estimate of $42.76 million.
For earnings history and earnings-related data on Radisys Corp (RSYS) click here.
... MoreTrading Radar for 2/9: Disney (DIS), Coca-Cola (KO), Viacom (VIAB), Nuance (NUAN), CVS Health (CVS) Report
February 8, 2016 2:35 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
AECOM Technology (NYSE: ACM) - consensus EPS $0.60
Agrium (NYSE: AGU) - consensus EPS $1.38
Allot Communications (Nasdaq: ALLT) - consensus EPS $0.04
American Superconductor (Nasdaq: AMSC) - consensus loss $0.49
Apollo Investment Corporation (Nasdaq: AINV) - consensus EPS $0.21
Belden (NYSE: BDC) -... More
